Claudia Fehling

Senior Director, Regulatory Affairs @Nimbus Therapeutics

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2024 — Present

Senior Director, Regulatory Affairs @Nimbus Therapeutics

View department →

Boston, MA, US

EDUCATION

N/A

Davidson College

BS, Biology

N/A

Johns Hopkins Bloomberg School of Public Health

Master of Public Health (MPH)

SKILLS

Clinical TrialsQuality SystemPharmaceutical IndustrySopFdaScienceQuality ControlGmpRegulatory RequirementsQuality AssuranceGlpOncologyGcpBiopharmaceuticalsU.s. Food and Drug Administration (Fda)HealthcareBiotechnologyRegulatory SubmissionsClinical DevelopmentTechnology TransferGxpLife SciencesQuality Auditing21 Cfr Part 11Medical DevicesClinical ResearchIso 13485Regulatory AffairsLifesciences

ABOUT CLAUDIA FEHLING

Accomplished regulatory affairs professional with 17 years of drug, biologic, and medical device regulatory experience• Regulatory Strategy Lead for INDs and CTAs and skilled in developing regulatory strategies to accelerate and de-risk product development• Guides strategic interactions and negotiations with Health Authorities• Successfully filed approximately 20 clinical trial applications (IND, CTA, or CTN), led approximately 30 health authority meetings, and filed Orphan Drug Designation (EU and US) and/or Fast Track Designation for over 15 products• Extensive experience with Orphan Drug and rare disease development programs as well as expedited development designations (Fast Track, Breakthrough Therapy, and Accelerated Approval Endpoints)• Experience spans small molecules, oligonucleotides, mAbs, therapeutic proteins, live biotherapeutics, vaccines, medical devices, and combination products across indications including neurology, oncology, immunology, antiviral, hepatology, gastroenterology, pulmonary, nephrology, endocrinology, metabolism, musculoskeletal, and urology

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.